Medtech finances future
CALCiViS, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announced it had secured £4.5 million in new equity from existing funders Archangel Investors and the Scottish Investment Bank and grant funding from the European Commission under its Horizon 2020 programme.
In August, it closed a £3.15 million equity funding round from Archangel Investors, Julz, and the Scottish Investment Bank. It will be used to support the completion of the FDA’s preview process for the CALCiViS Imaging System in the US, the world’s largest dentistry market.
Comments are closed here.